Identifying Cell Surface Antigens in HIV+ Individuals
Author Information
Author(s): Wu Jing Qin, Wang Bin, Belov Larissa, Chrisp Jeremy, Learmont Jenny, Dyer Wayne B, Zaunders John, Cunningham Anthony L, Dwyer Dominic E, Saksena Nitin K
Primary Institution: Westmead Millennium Institute
Hypothesis
The study aims to identify novel differential markers expressed on CD4+ and CD8+ T cells in HIV+ individuals using antibody microarray technology.
Conclusion
The study confirmed previously known cell surface antigens related to HIV disease stages and identified five novel antigens.
Supporting Evidence
- 17 statistically differential cell surface antigens were identified, including 5 novel ones.
- Changes in activation marker expression were more pronounced in CD8+ T cells.
- CD4+ T cells showed significant upregulation of HLA-DR in long-term non-progressors compared to other groups.
Takeaway
Researchers used a new technology to look at many markers on immune cells from people with HIV, finding some new markers that could help understand the disease better.
Methodology
The study used DotScan antibody microarray technology to analyze 135 different cell surface antigens on purified CD4+ and CD8+ T cells from HIV+ and HIV- individuals.
Potential Biases
Potential bias may arise from the selection of patient groups and the reliance on specific antibody markers.
Limitations
The study's findings may be limited by the small sample size and variability in antigen expression.
Participant Demographics
The study included 26 HIV+ individuals and 5 HIV- healthy individuals, with varying disease stages and treatment statuses.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website